Long-term sustained decline of anti-HCV neutralizing antibodies in HIV/HCV-coinfected patients after therapy-induced HCV clearance

被引:0
|
作者
Sepulveda-Crespo, Daniel [1 ,2 ]
Volpi, Camilla [1 ,3 ]
Amigot-Sanchez, Rafael [1 ]
Quero-Delgado, Marta [1 ]
Yelamos, Maria [4 ]
Diez, Cristina [2 ,5 ,6 ,7 ]
Gomez, Julian [4 ]
Hontanon, Victor [8 ,9 ,10 ]
Berenguer, Juan [2 ,5 ,6 ,7 ]
Gonzalez, Juan [2 ,8 ,9 ,10 ]
Martin-Escolano, Ruben [1 ,2 ]
Resino Garcia, Salvador [1 ,2 ]
Martinez, Isidoro [1 ,2 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Madrid, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Infecciosas CI, Madrid, Spain
[3] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy
[4] Univ Complutense, Fac Ciencias Quim, Dept Bioquim & Biol Mol, Madrid, Spain
[5] Unidad Enfermedades Infecciosas VIH, Madrid, Spain
[6] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
[7] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain
[8] Hosp Univ La Paz, Unidad VIH, Madrid, Spain
[9] Hosp Univ La Paz, Serv Med Interna, Madrid, Spain
[10] Inst Invest Hosp Univ La Paz, IdIPAZ, Madrid, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-407
引用
收藏
页码:S751 / S751
页数:1
相关论文
共 50 条
  • [21] Response to anti-HCV therapy in HIV-HCV-coinfected patients: does the lipid profile really have an effect?
    Petit, Jean-Michel
    Carrat, Fabrice
    Duong, Michel
    Halfon, Philippe
    Duvillard, Laurence
    Bani-Sadr, Firouze
    Chavanet, Pascal
    Cacoub, Patrice
    Piroth, Lionel
    ANTIVIRAL THERAPY, 2010, 15 (05) : 797 - 800
  • [22] Advanced liver fibrosis in HIV/HCV-coinfected patients on antiretroviral therapy
    Fuster, D
    Planas, R
    Muga, R
    Ballesteros, AL
    Santos, J
    Tor, J
    Sirera, G
    Guardiola, H
    Salas, A
    Cabré, E
    Ojanguren, I
    Barluenga, E
    Rey-Joly, C
    Clotet, B
    Tural, C
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (12) : 1293 - 1297
  • [23] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [24] Letter to the Editor: Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis
    Huang, Lixing
    Zou, Lingting
    HEPATOLOGY, 2025, 81 (01) : E5 - E5
  • [25] Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C)
    Sherman, Kenneth E.
    Andersen, Janet W.
    Butt, Adeel A.
    Umbleja, Triin
    Alston, Beverly
    Koziel, Margaret J.
    Peters, Marion G.
    Sulkowski, Mark
    Goodman, Zachary D.
    Chung, Raymond T.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010, 55 (05) : 597 - 605
  • [26] Long-term safety and tolerability of nevirapine and efavirenz-containing regimens in HIV/HCV-coinfected patients
    Mauelshagen, A.
    Horst, H.
    Stellbrink, H.
    Hoffmann, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 84 - 85
  • [27] PPARγ2 Pro12Ala Polymorphism Is Associated With Sustained Virological Response in HIV/HCV-Coinfected Patients Under HCV Therapy
    Fernandez-Rodriguez, Amanda
    Berenguer, Juan
    Rallon, Norma
    Jimenez-Sousa, Maria A.
    Carlos Lopez, Juan
    Soriano, Vicente
    Garcia-Alvarez, Monica
    Cosin, Jaime
    Martinez, Paula
    Guzman-Fulgencio, Maria
    Miralles, Pilar
    Miguel Benito, Jose
    Resino, Salvador
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (02) : 113 - 119
  • [28] Hepatitis C virus (HCV) relapses following the end of anti-HCV therapy are more frequent in HIV-coinfected patients
    Perez-Olmeda, M
    Rios, P
    Romero, M
    Nunez, M
    Garcia-Samaniego, J
    Soriano, V
    JOURNAL OF HEPATOLOGY, 2003, 38 : 163 - 163
  • [29] FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
    Daniel Pineda-Tenor
    Juan Berenguer
    María A Jiménez-Sousa
    Mónica García-Alvarez
    Teresa Aldámiz-Echevarria
    Ana Carrero
    Sonia Vázquez-Morón
    Pilar García-Broncano
    Cristina Diez
    Francisco Tejerina
    María Guzmán-Fulgencio
    Salvador Resino
    BMC Medicine, 12
  • [30] No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients
    Alejandro Di Lello, Federico
    Macias, Juan
    Plaza, Zulema
    Garcia-Rey, Silvia
    Soriano, Vicente
    Cifuentes, Celia
    del Mar Gonzalez, Maria
    Parra-Sanchez, Manuel
    Labarga, Pablo
    Recio, Eva
    Poveda, Eva
    Antonio Pineda, Juan
    ANTIVIRAL RESEARCH, 2012, 95 (02) : 67 - 71